Overview
Xiao-dong Teng practices in Shanghai, China. Their top areas of expertise are Renal Cell Carcinoma (RCC), Alveolar Soft Part Sarcoma, Myxoid Liposarcoma, and Hemangioblastoma.
Their clinical research consists of co-authoring 39 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adult Soft Tissue SarcomaTeng isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaTeng isExperienced. Learn about Alveolar Soft Part Sarcoma.
- AmebiasisTeng isExperienced. Learn about Amebiasis.
- ChondrosarcomaTeng isExperienced. Learn about Chondrosarcoma.
- Follicular Thyroid CancerTeng isExperienced. Learn about Follicular Thyroid Cancer.
- HemangioblastomaTeng isExperienced. Learn about Hemangioblastoma.